Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
Conditions: Shingles; Zoster Intervention: Biological: recombinant zoster vaccine Sponsor: Prof Patrice Lalive Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Multiple Sclerosis | Research | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine